The exploration of population pharmacokinetic model for meropenem in augmented renal clearance and investigation of optimum setting of dose

T Tamatsukuri, M Ohbayashi, N Kohyama… - Journal of Infection and …, 2018 - Elsevier
In recent years, augmented renal clearance (ARC), in which renal function is excessively
enhanced, has been reported, and its influence on β-lactam antibiotics has been …

The exploration of population pharmacokinetic model for meropenem in augmented renal clearance and investigation of optimum setting of dose

T Tamatsukuri - showa.repo.nii.ac.jp
In recent years, augmented renal clearance (ARC), in which renal function is excessively
enhanced, has been reported, and its influence on β-lactam antibiotics has been …

The exploration of population pharmacokinetic model for meropenem in augmented renal clearance and investigation of optimum setting of dose.

T Tamatsukuri, M Ohbayashi, N Kohyama… - Journal of Infection …, 2018 - europepmc.org
In recent years, augmented renal clearance (ARC), in which renal function is excessively
enhanced, has been reported, and its influence on β-lactam antibiotics has been …

The exploration of population pharmacokinetic model for meropenem in augmented renal clearance and investigation of optimum setting of dose.

T Tamatsukuri, M Ohbayashi, N Kohyama, Y Kobayashi… - 2018 - cabidigitallibrary.org
In recent years, augmented renal clearance (ARC), in which renal function is excessively
enhanced, has been reported, and its influence on β-lactam antibiotics has been …

The exploration of population pharmacokinetic model for meropenem in augmented renal clearance and investigation of optimum setting of dose

T Tamatsukuri, M Ohbayashi… - Journal of infection …, 2018 - pubmed.ncbi.nlm.nih.gov
In recent years, augmented renal clearance (ARC), in which renal function is excessively
enhanced, has been reported, and its influence on β-lactam antibiotics has been …

[引用][C] The exploration of population pharmacokinetic model for meropenem in augmented renal clearance and investigation of optimum setting of dose

T Tamatsukuri, M Ohbayashi, N Kohyama… - Journal of Infection …, 2018 - jglobal.jst.go.jp
Shibayama T, Sugiyama D, Kamiyama E, Tokui T, Hirota T, Ikeda T. Characterization of CS-
023 (RO4908463), a novel parenteral carbapenem antibiotic, and meropenem as substrates …

The exploration of population pharmacokinetic model for meropenem in augmented renal clearance and investigation of optimum setting of dose

T Tamatsukuri, M Ohbayashi, N Kohyama… - Journal of Infection and …, 2018 - jiac-j.com
In recent years, augmented renal clearance (ARC), in which renal function is excessively
enhanced, has been reported, and its influence on β-lactam antibiotics has been …

[PDF][PDF] The exploration of population pharmacokinetic model for meropenem in augmented renal clearance and investigation of optimum setting of dose

T Tamatsukuri - showa.repo.nii.ac.jp
In recent years, augmented renal clearance (ARC), in which renal function is excessively
enhanced, has been reported, and its influence on β-lactam antibiotics has been …